Your BHRC provider will build the right protocol based on your injury, goals, and health history virtually or in person
It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
These vitamins work together in our bodys metabolic pathways
Safety Information: Keep this product out of the reach of children
BPC-157 doesn't bind to GLP-1, GIP, insulin, or glucagon receptors
Without this link, providers face denials, rework, or incomplete data reporting for CMS quality metrics